All In Biotech

Drug Trial Radar · NCT02274623

Effect of CTAP101 Capsules on Ca/iPTH in Advanced Breast/Prostate Cancer Patients Treated With Denosumab/Zoledronic Acid

Effect of CTAP101 Capsules on Serum Calcium, Plasma Intact Parathyroid Hormone and Vitamin D Metabolites in Patients With Advanced Breast or Prostate Carcinomas With Metastases to Bone and Receiving Ongoing Therapy With Denosumab or Zoledronic Acid

Last checked: Nov 19, 2026Latest source record: Sep 27, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

33

Actual

Start

Dec 2014

Primary completion

Feb 27, 2017

Study completion Mar 17, 2017

Sponsor

Lead sponsor
OPKO Health, Inc.Industry
Sponsor type
Industry
First posted
Oct 24, 2014

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Supportive care
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is an open-label exploratory study of CTAP101 Capsules in patients with bone metastases arising from either breast or prostate cancer, who are taking anti-resorptive therapy.

Conditions

  • Breast Cancer
  • Prostate Cancer
  • Bone Neoplasms
  • Hypocalcemia
  • Hyperparathyroidism, Secondary

Interventions

  • CTAP101 CapsulesDrug

    escalating doses

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Effect of repeated, escalating doses of CTAP101 on serum calcium and plasma iPTH levelsTime frame: up to 52 weeks
  2. Effect of repeated, escalating daily doses of CTAP101 on serum calcifediolTime frame: up to 52 weeks
  3. Safety and tolerability of CTAP101Time frame: up to 52 weeks

Locations

6 sites in 1 country. Site status is shown where the registry gives one.

  • Coast Hematology-Oncology Associates

    Long Beach, California

  • Mount Sinai Medical Center, Comprehensive Cancer Center

    Miami, Florida

  • Research by Design LLC

    Evergreen Park, Illinois

  • Roswell Park Cancer Institute

    Buffalo, New York

  • University of Cincinnati Cancer Institute

    Cincinnati, Ohio

  • Inova Dwight and Martha Schar Cancer Center

    Fairfax, Virginia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.